IO STRIPES THROUGH BOX DESIGN

View On IC.GC.CA

REGISTERED

on 9 Sept 2019

Last Applicant/ Owned by

BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)

Route 206 & Province Line RoadPrinceton, NJ 08543

Serial Number

1891939 filed on 5^th Apr 2018

Registration Number

TMA1053356 registered on 9^th Sept 2019

Registration expiry Date

9^th Sept 2029

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

M5X1G5

IO STRIPES THROUGH BOX DESIGN

Trademark usage description

pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, heart failure, Read More

Vienna Information

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 12

Quadrilaterals containing one or more other geometrical figures -- Note: Including quadrilaterals containing bent or straight lines (except 26.4.11).Quadrilatères contenant une ou plusieurs autres figures géométriques -- Note: Y compris les quadrilatères contenant des lignes courbées ou droites (excepté 26.4.11).

26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 5

Thin linesLignes fines

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

Classification Information

Class [005]
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents.

Classification kind code

Mark Details

Serial Number

1891939

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 14^th Aug 2019	Registration Pending
Submitted for opposition 42 on 22^nd May 2019	Advertised
Submitted for opposition 26 on 2^th May 2019	Approved
Submitted for opposition 27 on 12^th Mar 2019	Approval Notice Sent
Submitted for opposition 135 on 15^th Feb 2019	Amendment to Application
Submitted for opposition 22 on 20^th Jul 2018	Search Recorded
Submitted for opposition 20 on 20^th Jul 2018	Examiner's First Report
Submitted for opposition 31 on 10^th Apr 2018	Formalized
Submitted for opposition 30 on 5^th Apr 2018	Filed
Submitted for opposition 1 on 5^th Apr 2018	Created